Wyss Institute’s iNodes Team Secures ARPA-H Award to Advance Implantable Immune Organs for Ovarian Cancer Treatment

The Wyss Institute at Harvard University has received an ARPA-H Sprint for Women’s Health award to advance iNodes, an innovative …

Continue ›››

Jimini Health Launches with $8M Seed Funding to Advance Mental Health Care

Stanford-based Jimini Health, a mental health startup founded in 2023, has announced its official launch with $8 million in seed …

Continue ›››

Axsome Therapeutics Announces Positive Phase 3 Results for Reboxetine in Narcolepsy

Axsome Therapeutics announced that its investigational treatment, AXS-12 (reboxetine), met the primary endpoint in the ENCORE Phase 3 trial. The …

Continue ›››

Novo Holdings Supports $135 Million Funding to Advance Adcendo’s Antibody-Drug Conjugate Development

Novo Holdings has joined a $135 million Series B financing round for Adcendo, a clinical-stage biotechnology company headquartered in Copenhagen, …

Continue ›››

Valence Labs and Recursion Launch OpenQDC: The Largest Public Quantum Mechanical Dataset for ML Research

Researchers at Valence Labs, powered by Recursion, have introduced OpenQDC (Open Quantum Data Commons), an extensive, publicly accessible quantum mechanical …

Continue ›››

Roche Expands Cell Therapy Portfolio with $1.5 Billion Poseida Therapeutics Acquisition

Swiss pharmaceutical giant Roche has announced its acquisition of Poseida Therapeutics, a San Diego-based biotech company specializing in next-generation cell …

Continue ›››

A New Genetic Insight into Mitochondrial DNA Depletion Syndrome

Japanese researchers have identified a novel genetic cause for hepatocerebral mitochondrial DNA depletion syndrome (MTDPS), linking it to variants in …

Continue ›››

Communication, Staffing, Technology: The Persistent Barriers in Clinical Trials

Today, we’re diving into the results of Advarra’s 2024 Site-Sponsor-CRO Collaboration Survey, which highlights three major barriers hindering collaboration in …

Continue ›››

M42 CEO Hasan Jasem Al Nowais Calls for a Global Shift Toward Preventative Healthcare

At the 7th Annual Longevity Forum in London, Hasan Jasem Al Nowais, Managing Director and Group CEO of M42, delivered …

Continue ›››

Lantern Pharma Expands Phase 2 Harmonic Clinical Trial to Japan and Taiwan

Lantern Pharma (NASDAQ: LTRN) has dosed the first patient in Japan as part of the expansion of its Phase 2 …

Continue ›››

Cradle Raises $73M for Gen-AI Protein Engineering

Cradle has secured $73 million in a Series B funding round led by IVP, bringing its total funding to over …

Continue ›››

LongeVC Announces Investment in Glyphic Biotechnologies, Developing Single-Molecule Protein Sequencing

LongeVC has announced its investment in Glyphic Biotechnologies, a company developing single-molecule protein sequencing technology.

Continue ›››